Premium
Psychiatric comorbidity, depression, and anxiety levels and quality of life of the patients with mycosis fungoides
Author(s) -
Engin Burhan,
Keçici Ayşegül Sevim,
Uzun Aslıhan Özge,
Yalçın Murat
Publication year - 2020
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/dth.13922
Subject(s) - beck anxiety inventory , medicine , depression (economics) , beck depression inventory , anxiety , mycosis fungoides , quality of life (healthcare) , comorbidity , disease , psychiatry , clinical psychology , lymphoma , economics , macroeconomics , nursing
Mycosis fungoides (MF) is a chronic disease, causing serious morbidities and mortality. This study was designed to measure depression and anxiety levels in MF patients, and quality of life (QoL) assessments and to compare the results with controls. Fifty‐two patients with a diagnosis of MF and 52 age and sex matching healthy controls were enrolled in this study. Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI) and the 36‐Item Short Form Health Survey (SF‐36) were administered to all patients and controls. Mean BAI and BDI scores of the patients with MF were significantly higher than controls. In case of the SF‐36, general health perception, emotional, and social functioning scores were significantly lower in MF patients. Depression scores of the patients' were positively correlated with the age of disease onset and negatively correlated with physical functioning scores. Significant negative correlation was detected between eight subscales of the SF‐36 and BDI and BAI scores. This study has demonstrated that there is significant impairment of QoL in MF patients MF, with higher anxiety and depression levels, when compared to control group. As the disease progresses, level of depression increases and patients' general health perception deteriorates.